Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease (LOPD)
![](/.imaging/webp/sanofi-templates/article-hero-w768/dam/campus-sanofi-ae/Articles/science-hero-(6).webp0/jcr:content/science%20hero%20(6).webp)
Objective and Method
![](/dam/jcr:20666c2c-8e69-407f-8bb9-9a738a0e5599/Asset%204@4x-100%20(2).webp)
Consensus based on literature supporting clinical presentation and recommendations
Literature Analysis on LOPD Symptoms (Neurology): Hierarchy of Evidence
![](/dam/jcr:98329dec-578e-4fb5-ae8a-4720c8a11cd3/Asset%205@4x.jpg)
- Delayed motor milestones
- Low/absent reflexes
- Mild facial muscle weakness
- HyperCKemia/paucisymptomatic
- Negative SMA/DMD
- Shortness of breath at rest or on effort
- Muscle pain and elevated ALT/AST
- Gait abnormalities
- Scoliosis/scapular winging
- Disproportional weakness of the neck flexors and difficulty in raising the head
- LGMW
- Swallowing difficulties
- Frequent falls
- Difficulty chewing/jaw muscle fatigue
- Difficulty in walking and climbing stairs
- Double-seronegative MG
- Muscle pain and elevated ALT/AST
- Gait abnormalities
- HyperCKemia/paucisymptomatic
- Unexplained myopathy
- Scoliosis/scapular winging
High CK/elevated LDH,
ALT,and AST
Family history of unexplained
muscle weakness or respiratory
failure
Proposed Diagnostic Algorithm for Neurologists During the Second Meeting
Conclusion
![](/dam/jcr:27ebc9fb-85e1-4d29-96ef-4b8d44434c27/Asset%2029@4x.jpg)
![](/dam/jcr:01e59ee6-8d81-467b-accb-461e615fb47c/Asset%2033@4x%20(1).jpg)
Recommendation
Testing for Pompe disease must be done if any one specialty-specific symptom plus elevated CK/LDH/ALT/AST or a family history of unexplained muscle weakness is prese
*The age of patients with pediatric/juvenile LOPD ranges from 1 to 17 years; #The age of patients with adult LOPD is usually 18 years and above.
Abbreviations
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CK: Creatine kinase; DBS: Dried blood spot testing; DMD: Duchenne muscular dystrophy; KSA: Kingdom of Saudi Arabia; LDH: Lactate dehydrogenase; LGMW: Limb–girdle muscle weakness; LOPD: Late-onset Pompe disease; MG: Myasthenia gravis; SMA: Spinal muscular atrophy; UAE: United Arab Emirates.
Reference
- Al Shehri A, Al-Asmi A, Al Salti AM, et al. A multidisciplinary perspective addressing the diagnostic challenges of late-onset Pompe disease in the Arabian Peninsula region developed from an Expert Group Meeting. J Neuromuscul Dis. 2022;9(5):661–673.